OncoLink Cancer Treatment and Resources

OncoLink Blogs
English Donar
Oncolink Features

Find My Cancer Drug

ABCDEF
GHILMN
OPRSTV


Profesionales de la salud   /     /     /     /  

Epoetin Alfa Treatment Improves Quality of Life and Increases Hemoglobin Levels during Chemotherapy for Lymphoma, Chronic Lymphocytic Leukemia (CLL), and Multiple Myeloma (MM) Patients with Mild-to-Moderate Anemia
Presenter: David J. StrausPresenter's Affiliation: Memorial Sloan Kettering Cancer Center/ Procrit Hematologic Malignancies Study GroupType of Session: ScientificBackground Anemia affects up to 80% of patients with hematologic malignancies. While...
Low-Dose Thalidomide and Dexamethasone Improves Survival in Advanced Multiple Myeloma
Presenter: Antonio PalumboPresenter's Affiliation: Divisione di Ematologia dell'Unversita di TorinoType of Session: ScientificBackground The standard treatment for multiple myeloma (MM)for decades had been melphalan and prednisone. High dose...
Non-Myeloablative Radio-Immunotherapy With a Iodine-131-Tagged Anti-CD30 Antibody (131I-Ki-4) in Patients With Refractory Hodgkin's Lymphoma
Presenter: Roland SchnellPresenter's Affiliation: University of CologneType of Session: ScientificBackground Relapsed Hodgkin's Disease (HD) has a poor prognosis. More treatment alternatives are neeeded. HD is a good target for immunotherapy...
Replicating Attenuated Measles Virus Can Be Engineered to Enter Cells Through the CD20 Antigen
Presenter: Adele FieldingPresenter's Affiliation: Mayo ClinicType of Session: ScientificBackground In laboratory models of Non-Hodgkin's Lymphoma (NHL), attenuated measles virus (MV) has been found to have therapeutic potential as a replicating,...
Time to First Progression Is the Best Predictor of Survival Duration in SWOG Standard Dose Chemotherapy Studies
Presenter: Brian G.M. DuriePresenter's Affiliation: SWOGType of Session: ScientificBackground Multiple myeloma has been treated with combination chemotherapy for years. Various regimens have various response rates and have been used in the past to...
Zoledronic Acid, Hypocalcemia and Renal Dysfunction in Thalidomide-Treated Myeloma Patients
Presenter: Bethan MyersPresenter's Affiliation: Queen's Medical Centre, University Hospital, NottinghamType of Session: ScientificBackground Zoledronic acid (Zometa) is a new bisphosphonate hundreds to thousands of times more potent than it's...
OncoLink I wish u knew...

Ms. Bruning talks about working in development for a cancer center and how this translates to hope in cancer care. Read more.

Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet

Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy
Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies

Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer

Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults

OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews


Ask the Experts
Brown Bag Chat
Tracy's Corner

About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement

OncoLink Cancer Resources RSS What's New RSS

Mapa de Sitio   |   Contactar OncoLink   |   Declaración de Privacidad   |   Responsabilidad Legal   |   Enlace a OncoLink   |   Início
Para la ayuda visite por favor nuestro Sección de la AYUDA

Trustees of the University of Pennsylvania